Cited by 97Protein Tyrosine PhosphatasesProtein Kinase Regulation and GTPase SignalingSignaling Pathways in Disease

Mechanisms of site‐specific dephosphorylation and kinase opposition imposed by PP2A regulatory subunits

Open access
Kruse, Thomas, Gnosa, Sebastian Peter, Nasa, Isha, Garvanska, Dimitriya Hristoforova, Hein, Jamin B, Nguyen, Hieu, Samsøe‐Petersen, Jacob, Lopez‐Mendez, Blanca +7 more·2020·The EMBO Journal

Abstract

PP2A is an essential protein phosphatase that regulates most cellular processes through the formation of holoenzymes containing distinct regulatory B‐subunits. Only a limited number of PP2A‐regulated phosphorylation sites are known. This hampers our understanding of the mechanisms of site‐specific dephosphorylation and of its tumor suppressor functions. Here, we develop phosphoproteomic strategies for global substrate identification of PP2A‐B56 and PP2A‐B55 holoenzymes. Strikingly, we find that B‐subunits directly affect the dephosphorylation site preference of the PP2A catalytic subunit, resulting in unique patterns of kinase opposition. For PP2A‐B56, these patterns are further modulated by affinity and position of B56 binding motifs. Our screens identify phosphorylation sites in the cancer target ADAM17 that are regulated through a conserved B56 binding site. Binding of PP2A‐B56 to ADAM17 protease decreases growth factor signaling and tumor development in mice. This work provides a roadmap for the identification of phosphatase substrates and reveals unexpected mechanisms governing PP2A dephosphorylation site specificity and tumor suppressor function.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15252/embj.2019103695

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • B56α interacts with up to 100 cellular target proteins.

    “B56α interacts with up to 100 cellular target proteins (Supplementary Data 1 and 10,11) among which, it is best known by its capacity to inhibit oncogenic activity of MYC12,13.”

    From Structural mechanism for inhibition of PP2A-B56α and oncogenicity by CIP2A (2023) · cites this paper as [11]

    The Results section, “Development of a specific PP2A-B56 inhibitor” (page unavailable), reports cellular proteins that interact with YFP-B56α, supporting the interaction part of the claim. It does not give a count approaching 100 B56α interactors. The 651 proteins reported in “Identification of PP2A-dependent phosphorylation sites” are proteins with increased phosphorylation, not a count of B56α-binding targets. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • B′ subunits require an intact A subunit for binding, as deduced from in vitro experiments and mouse models.

    “Limited insights have been gained from the B’ subunits, which require an intact A subunit for binding, as deduced from in vitro experiments and mouse models.”

    From Targeting PP2A in cancer: an underrated option (2025) · cites this paper as [59]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kruse, T., Gnosa, S. P., Nasa, I., Garvanska, D. H., Hein, J. B., Nguyen, H., Samsøe‐Petersen, J., Lopez‐Mendez, B., Hertz, E. P. T., Schwarz, J., Pena, H. S., Nikodemus, D., Kveiborg, M., Kettenbach, A. N., & Nilsson, J.
Affiliations
  • University of Copenhagen (DK)
  • Dartmouth College (US)
Corresponding author
  • Kveiborg, Marie
  • Kettenbach, Arminja N
  • Nilsson, Jakob
Venue
The EMBO Journal
Published
2020-05-13
Volume
39
Issue
13
Pages
e103695-e103695
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W3024517740
Cited by
97
References
58
Citations by year
2026: 10 · 2025: 12 · 2024: 16 · 2023: 25 · 2022: 7 · 2021: 17 · 2020: 10
FWCI
4.78
Type
journal article
Language
en
Open access
Locations
  • The EMBO Journal (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
Funders
  • Novo Nordisk Foundation (NNF14CC0001, NNF18OC0053124)
  • Kræftens Bekæmpelse (R146‐A9211‐16‐S2, R167‐A10951‐17‐S2)
  • Independent Research Fund Denmark (8021‐00101B, 7016 00086)
  • NIH/NIGMS (R35GM119455, P20GM113132)
  • NIH (S10‐OD016212)
  • Marie Sklodowska Curie Grant (798716)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Keywords
protein phosphatase 2A, PP2A-B56, PP2A-B55, phosphoproteomics, ADAM17, tumor suppressor function, growth factor signaling, carcinogenesis
MeSH terms
ADAM17 Protein, Animals, Binding Sites, HeLa Cells, Humans, Phosphorylation, Amino Acid Motifs, Mice, Protein Phosphatase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review